Rice Hall James & Associates’s Inogen INGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-46,044
Closed -$3M 316
2021
Q2
$3M Sell
46,044
-1,977
-4% -$125K 0.11% 147
2021
Q1
$2.52M Buy
48,021
+185
+0.4% +$9.23K 0.08% 173
2020
Q4
$2.14M Buy
47,836
+8,516
+22% +$294K 0.08% 183
2020
Q3
$1.14M Buy
39,320
+3,543
+10% +$111K 0.05% 225
2020
Q2
$1.27M Buy
35,777
+24,352
+213% +$1.03M 0.05% 196
2020
Q1
$590K Buy
+11,425
New +$549K 0.03% 231
2017
Q3
Sell
-21,210
Closed -$2.02M 296
2017
Q2
$2.02M Sell
21,210
-1,289
-6% -$110K 0.09% 190
2017
Q1
$1.75M Sell
22,499
-500
-2% -$34.6K 0.09% 210
2016
Q4
$1.54M Sell
22,999
-7,154
-24% -$441K 0.08% 222
2016
Q3
$1.81M Sell
30,153
-200
-0.7% -$11.1K 0.09% 199
2016
Q2
$1.52M Sell
30,353
-730
-2% -$34.8K 0.09% 210
2016
Q1
$1.4M Hold
31,083
0.08% 220
2015
Q4
$1.25M Sell
31,083
-200
-0.6% -$8.46K 0.07% 229
2015
Q3
$1.52M Buy
31,283
+500
+2% +$23.7K 0.1% 202
2015
Q2
$1.37M Sell
30,783
-18,190
-37% -$698K 0.08% 235
2015
Q1
$1.57M Sell
48,973
-34,063
-41% -$1.1M 0.09% 221
2014
Q4
$2.6M Buy
+83,036
New +$2.01M 0.16% 168

Other funds holding INGN

Rice Hall James & Associates's INGN Position: Q3 2021 in Review

Rice Hall James & Associates sold out of Inogen (INGN) in Q3 2021, closing a stake of 46,044 shares — an estimated $3M sold.

Rice Hall James & Associates first reported a position in INGN in Q4 2014 and held it in 17 quarters. The position peaked at $3M in Q2 2021. 170 funds tracked by Wall St. Rank hold INGN as of Q3 2021.

  • Rice Hall James & Associates reported no remaining Inogen position as of Q3 2021 after selling out during the quarter.
  • Rice Hall James & Associates sold 46,044 Inogen shares in Q3 2021, an estimated $3M.
  • Rice Hall James & Associates first reported a position in Inogen in Q4 2014 and held it in 17 quarters.
  • Rice Hall James & Associates's Inogen position peaked at $3M in Q2 2021.
  • 170 funds tracked by Wall St. Rank held Inogen as of Q3 2021.

Based on Rice Hall James & Associates's 13F filing for Q3 2021, filed 9 Nov 2021.